Cargando…
Exubera(®) (inhaled insulin): an evidence-based review of its effectiveness in the management of diabetes
INTRODUCTION: Inadequate glycemic control contributes to the development and progression of complications, which are associated with a significant economic burden on healthcare systems. However, optimal glycemic control is difficult to sustain with oral antidiabetic agents and adherence to intensive...
Autor principal: | Profit, Louise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321660/ https://www.ncbi.nlm.nih.gov/pubmed/22500147 |
Ejemplares similares
-
Inhaled human insulin (Exubera®): clinical profile and patient considerations
por: Barnett, Anthony H, et al.
Publicado: (2007) -
Will availability of inhaled human insulin (Exubera(®)) improve management of type 2 diabetes? The design of the Real World trial
por: Freemantle, Nick, et al.
Publicado: (2006) -
Two-Year Pulmonary Safety and Efficacy of Inhaled Human Insulin (Exubera) in Adult Patients With Type 2 Diabetes
por: Rosenstock, Julio, et al.
Publicado: (2008) -
Pulmonary and cardiovascular safety of inhaled insulin in routine practice: The Exubera Large Simple Trial (VOLUME)
por: Gatto, Nicolle M., et al.
Publicado: (2019) -
Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas
por: Smith, David B., et al.
Publicado: (2007)